Find the latest Elevation Oncology, Inc. (ELEV) stock quote, history, news and other vital information to help you with your stock trading and investing.

Mar 21, 2025 · Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a clinically validated molecular target.

5 days ago · Get a real-time Elevation Oncology, Inc. (ELEV) stock price with an overview of financials, statistics, forecasts, charts and more.

Mar 20, 2025 · ELEV | Complete Elevation Oncology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Get the latest Elevation Oncology Inc (ELEV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Discover real-time Elevation Oncology, Inc. Common stock (ELEV) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

5 days ago · See the latest Elevation Oncology Inc stock price (ELEV:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Mar 21, 2025 · A high-level overview of Elevation Oncology, Inc. (ELEV) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Mar 19, 2025 · Explore Elevation Oncology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ELEV. Elevation Oncology's ADCs target CLDN18.2 and HER3, with EO-3021...

We are focused on discovering and developing selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.